Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-18-014676
Filing Date
2018-10-30
Accepted
2018-10-30 17:05:45
Documents
4
Period of Report
2018-11-08

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a1018_actiniumpharma.htm PRE 14A 413771
2 GRAPHIC image_001.jpg GRAPHIC 25910
3 GRAPHIC proxy1.jpg GRAPHIC 204815
4 GRAPHIC proxy2.jpg GRAPHIC 255554
  Complete submission text file 0001213900-18-014676.txt   1084845
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36374 | Film No.: 181147725
SIC: 2834 Pharmaceutical Preparations